The closing price of Dyne Therapeutics Inc (NASDAQ: DYN) was $25.16 for the day, down -4.84% from the previous closing price of $26.44. In other words, the price has decreased by -$1.28 from its previous closing price. On the day, 1843798 shares were traded.
Ratios:
Our analysis of DYN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.53. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 20, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On February 27, 2023, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $16 to $27.
On February 15, 2023, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $34.Oppenheimer initiated its Outperform rating on February 15, 2023, with a $34 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 01 ’24 when Brumm Joshua T sold 94,480 shares for $29.04 per share. The transaction valued at 2,743,718 led to the insider holds 563,471 shares of the business.
Rhodes Jason P sold 46,534 shares of DYN for $1,398,347 on Mar 01 ’24. The Director now owns 847,388 shares after completing the transaction at $30.05 per share. On Mar 01 ’24, another insider, Atlas Venture Opportunity Fund, who serves as the 10% Owner of the company, sold 29,435 shares for $30.05 each. As a result, the insider received 884,522 and left with 1,458,691 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 2.06B and an Enterprise Value of 1.97B.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $30.27, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is 20.71, while the 200-Day Moving Average is calculated to be 13.11.
Shares Statistics:
DYN traded an average of 2.05M shares per day over the past three months and 2M shares per day over the past ten days. A total of 61.47M shares are outstanding, with a floating share count of 39.82M. Insiders hold about 50.90% of the company’s shares, while institutions hold 52.76% stake in the company. Shares short for DYN as of Feb 15, 2024 were 7.25M with a Short Ratio of 3.54, compared to 7.97M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.94% and a Short% of Float of 11.18%.
Earnings Estimates
The firm’s stock currently is rated by 8 analysts. On average, analysts expect EPS of -$0.77 for the current quarter, with a high estimate of -$0.58 and a low estimate of -$0.83, while EPS last year was -$0.78. The consensus estimate for the next quarter is -$0.76, with high estimates of -$0.57 and low estimates of -$0.87.
Analysts are recommending an EPS of between -$2.29 and -$3.6 for the fiscal current year, implying an average EPS of -$3.17. EPS for the following year is -$2.96, with 7 analysts recommending between -$2.19 and -$4.48.
